220 related articles for article (PubMed ID: 34341073)
21. Conserved and non-conserved enhancers direct tissue specific transcription in ancient germ layer specific developmental control genes.
Chatterjee S; Bourque G; Lufkin T
BMC Dev Biol; 2011 Oct; 11():63. PubMed ID: 22011226
[TBL] [Abstract][Full Text] [Related]
22. PAX9 functions as a tumor suppressor gene for cervical cancer via modulating cell proliferation and apoptosis.
Liu J; Wang YQ; Niu HB; Zhang CX
Kaohsiung J Med Sci; 2022 Apr; 38(4):357-366. PubMed ID: 34931758
[TBL] [Abstract][Full Text] [Related]
23. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.
Li H; Mar BG; Zhang H; Puram RV; Vazquez F; Weir BA; Hahn WC; Ebert B; Pellman D
Blood; 2017 Jan; 129(4):497-508. PubMed ID: 27756750
[TBL] [Abstract][Full Text] [Related]
24. PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma.
Bhol CS; Mishra SR; Patil S; Sahu SK; Kirtana R; Manna S; Shanmugam MK; Sethi G; Patra SK; Bhutia SK
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166428. PubMed ID: 35533906
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer.
Zheng Y; Wang Z; Wei S; Liu Z; Chen G
Cancer Lett; 2021 Feb; 499():148-163. PubMed ID: 33253790
[TBL] [Abstract][Full Text] [Related]
27. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival.
Muratovska A; Zhou C; He S; Goodyer P; Eccles MR
Oncogene; 2003 Sep; 22(39):7989-97. PubMed ID: 12970747
[TBL] [Abstract][Full Text] [Related]
28. HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma.
Law CT; Wei L; Tsang FH; Chan CY; Xu IM; Lai RK; Ho DW; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2019 May; 69(5):2013-2030. PubMed ID: 30516846
[TBL] [Abstract][Full Text] [Related]
29. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.
Sun F; Chan E; Wu Z; Yang X; Marquez VE; Yu Q
Mol Cancer Ther; 2009 Dec; 8(12):3191-202. PubMed ID: 19934278
[TBL] [Abstract][Full Text] [Related]
30. CRISPR screen identifies the NCOR/HDAC3 complex as a major suppressor of differentiation in rhabdomyosarcoma.
Phelps MP; Bailey JN; Vleeshouwer-Neumann T; Chen EY
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15090-15095. PubMed ID: 27956629
[TBL] [Abstract][Full Text] [Related]
31. Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.
Buonomo T; Carraresi L; Rossini M; Martinelli R
J Transl Med; 2011 Jan; 9():2. PubMed ID: 21205295
[TBL] [Abstract][Full Text] [Related]
32. The small cell lung cancer-specific isoform of RE1-silencing transcription factor (REST) is regulated by neural-specific Ser/Arg repeat-related protein of 100 kDa (nSR100).
Shimojo M; Shudo Y; Ikeda M; Kobashi T; Ito S
Mol Cancer Res; 2013 Oct; 11(10):1258-68. PubMed ID: 23928058
[TBL] [Abstract][Full Text] [Related]
33. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer.
He T; Wildey G; McColl K; Savadelis A; Spainhower K; McColl C; Kresak A; Tan AC; Yang M; Abbas A; Dowlati A
Mol Oncol; 2021 Jan; 15(1):195-209. PubMed ID: 33084222
[TBL] [Abstract][Full Text] [Related]
34.
Li L; Li W; Chen N; Zhao H; Xu G; Zhao Y; Pan X; Zhang X; Zhou L; Yu D; Li A; Hu JF; Cui J
Clin Cancer Res; 2019 Feb; 25(4):1302-1317. PubMed ID: 30429198
[TBL] [Abstract][Full Text] [Related]
35. Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer.
Luo H; Shan J; Zhang H; Song G; Li Q; Xu CX
Semin Cancer Biol; 2022 Nov; 86(Pt 3):960-970. PubMed ID: 35189321
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
38. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
[TBL] [Abstract][Full Text] [Related]
39. Six2 regulates Pax9 expression, palatogenesis and craniofacial bone formation.
Sweat YY; Sweat M; Mansaray M; Cao H; Eliason S; Adeyemo WL; Gowans LJJ; Eshete MA; Anand D; Chalkley C; Saadi I; Lachke SA; Butali A; Amendt BA
Dev Biol; 2020 Feb; 458(2):246-256. PubMed ID: 31765609
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small-Cell Lung Cancer.
Kong R; Patel AS; Sato T; Jiang F; Yoo S; Bao L; Sinha A; Tian Y; Fridrikh M; Liu S; Feng J; He X; Jiang J; Ma Y; Grullon K; Yang D; Powell CA; Beasley MB; Zhu J; Snyder EL; Li S; Watanabe H
Am J Respir Crit Care Med; 2022 Dec; 206(12):1480-1494. PubMed ID: 35848993
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
